Middle,Aged,Woman,Daughter,Taking,Care,Of,Her,Senior,Father

These findings may one day lead to social recognition memory treatment options for Alzheimer's patients. (Credit: 9nong on Shutterstock)

In A Nutshell

  • Protective “nets” around neurons in the brain’s CA2 region disintegrate in Alzheimer’s mice, coinciding precisely with loss of social recognition memory
  • Mice with damaged nets couldn’t recognize other mice they’d met before, even though other types of memory stayed intact
  • An enzyme-blocking drug preserved both the protective nets and social memory in treated mice
  • The research identifies overactive “molecular scissors” (matrix metalloproteinases) as the culprit shredding these critical brain structures

When Sarah’s mother stopped recognizing her last year, it wasn’t a gradual process. One Tuesday afternoon, her mom looked at her with polite confusion and asked, “Have we met before?” For Sarah, like millions of adult children watching parents disappear into Alzheimer’s, that moment represents the disease at its most devastating. The anguish isn’t merely over lost memories, but losing the people we love while they’re still alive.

Now, researchers at the University of Virginia School of Medicine have identified a brain change in mice that may help explain this heartbreaking symptom. Their study, published in Alzheimer’s & Dementia, reveals that the loss of social recognition memory (the ability to remember faces, names, and relationships) is linked to destruction of protective structures around neurons in one specific brain region. More importantly, they’ve shown that blocking this destruction in mice prevents the loss of social memory entirely.

The findings offer a mechanistic explanation in mice that may clarify why some people with Alzheimer’s eventually fail to recognize their own children, spouses, and lifelong friends—a symptom that many families describe as more painful than any other aspect of the disease.

How Brain Protection Breaks Down in Alzheimer’s Disease

The culprit turns out to be the breakdown of perineuronal nets, specialized coatings that wrap around neurons like biological armor. These intricate lattices of proteins and sugar molecules normally stabilize the connections between brain cells and preserve memory circuits. In a tiny region of the hippocampus called CA2 (barely a few millimeters across), these nets surround the neurons specifically responsible for social recognition.

Using 5XFAD mice (a model that develops Alzheimer’s-like symptoms), the research team watched this protection disintegrate. At six months of age, the mice showed profound disruption of their CA2 perineuronal nets. Right on schedule, they lost the ability to recognize other mice they’d previously met, even though their other types of memory remained intact.

The authors report the loss was most striking in CA2 compared with subtler changes elsewhere. What makes this finding particularly cruel is its precision. The mice could still remember objects they’d seen before. Their brains weren’t failing wholesale—just the specific circuit responsible for recognizing other individuals was going dark.

Scientists have learned to be skeptical about correlation. Just because two things happen together doesn’t mean one causes the other. So the team conducted experiments designed to prove that perineuronal net loss actually drives social memory failure rather than simply accompanying it.

They used genetic techniques and enzymes to selectively remove these nets from the CA2 region in healthy mice whose brains were otherwise normal. The results left no room for doubt: mice with damaged CA2 nets lost their social recognition abilities even without Alzheimer’s disease.

The reversibility experiments proved even more revealing. When researchers used an enzyme that temporarily dissolves perineuronal nets, the mice lost social memory within five days. But the nets regrew naturally by two weeks, and social memory returned with them. The neurons themselves were fine; they just needed their protective coating restored.

This reversibility matters enormously for treatment prospects. If the underlying neurons are still alive and functional, just unprotected, then restoring that protection might reverse symptoms rather than merely slowing decline.

Harald Sontheimer, PhD, chair of the University of Virginia School of Medicine's Department of Neuroscience
“Finding a structural change that explains a specific memory loss in Alzheimer’s is very exciting,” said Harald Sontheimer, PhD, chair of the University of Virginia School of Medicine’s Department of Neuroscience and a member of the UVA Brain Institute. “It is a completely new target, and we already have suitable drug candidates in hand.” (Credit: University of Virginia Communications)

Why Brain Cells Lose Their Protective Coating

Digging into the molecular details, the researchers discovered why these protective structures fall apart. They used RNA sequencing to analyze which genes were turned up or down in the CA2 region at different disease stages.

The pattern revealed an imbalance between biological processes that build and tear down perineuronal nets. Multiple enzymes called matrix metalloproteinases (molecular scissors that normally remodel tissue in controlled ways) showed higher transcript levels for several remodeling enzymes. These enzymes were essentially shredding the protective nets faster than cells could rebuild them.

In healthy brains, matrix metalloproteinases serve useful purposes, carefully trimming and reshaping the extracellular environment. In Alzheimer’s-affected brains, they ramp up, working overtime to destroy structures that should remain stable.

Other enzymes that normally inhibit these molecular scissors showed compensatory increases, suggesting the brain was trying to fight back. But the balance had tipped too far. The destruction outpaced repair, leaving critical neurons exposed and vulnerable.

Drug Treatment Prevents Memory Loss in Mice

This molecular mechanism pointed toward a potential treatment. If overactive enzymes are destroying the nets, what would happen if those enzymes were blocked?

The team used a broad MMP blocker (GM6001) that targets several enzymes. They started treatment at five months of age in the 5XFAD mice (after biological changes had begun but before social memory typically fails). Think of it as stepping in during the early disease process rather than waiting for symptoms to appear.

After one month of daily injections, mice receiving GM6001 maintained both their CA2 perineuronal nets and their social recognition abilities. Untreated mice showed the expected deterioration in both areas. The drug essentially prevented the molecular scissors from destroying the protective coating around critical memory neurons.

When Patients Stop Recognizing Family Members

Social recognition encompasses more than just remembering what someone looks like. It includes recalling names and voices, remembering shared experiences, reading facial expressions, understanding relationships, and maintaining emotional connections. When this system breaks down in Alzheimer’s patients, the effects ripple through every interaction.

The progression often starts subtly. A patient might take longer to recognize a familiar face or struggle to recall a neighbor’s name. As the disease advances, the impairments become more severe: difficulty recognizing friends, confusion about family relationships, failure to recognize a spouse’s voice on the phone. Eventually, many patients reach the stage where they no longer recognize their own children.

For caregivers and family members, this loss carries unique pain. The patient is physically present but emotionally absent. Conversations that once flowed naturally become awkward exchanges with a stranger. The comfort of familiar presence dissolves into confusion.

Co-author Harald Sontheimer explained that when patients lose spatial memory and get lost, that’s frightening, but when they no longer recognize their daughter’s face, something more fundamental to the relationship is broken.

The University of Virginia study found that CA2 damage selectively impairs social cognition while leaving other hippocampus-dependent memories intact. The mice in their experiments could still distinguish between familiar and novel objects. Standard memory was working fine. Only the social recognition circuit had failed.

One unexpected finding emerged from examining where pathology appears in Alzheimer’s-affected brains. Amyloid plaques (the protein clumps that have dominated Alzheimer’s research for decades) carpet most of the hippocampus in these mice. But they largely avoid the CA2 region.

Perineuronal net destruction happens independently of the disease’s most famous hallmark. The protective coatings are dissolving even though classic Alzheimer’s pathology hasn’t accumulated in that specific spot.

The researchers also found no evidence of neuron death in CA2 at the ages when nets were disrupted and social memory impaired. The cells themselves were still alive, just stripped of their protection. This timing matters enormously for treatment. If intervention can happen before neurons die, the potential for recovery or stabilization remains.

Perineuronal net disruption appeared not only in 5XFAD mice but also in two other Alzheimer’s models: J20 and 3XTg strains. This consistency across different genetic backgrounds suggests the mechanism operates broadly rather than representing a quirk of one particular model.

Have Alzheimer's researchers focused too much on toxic protein accumulation?
Have Alzheimer’s researchers focused too much on toxic protein accumulation? (Credit: Gorodenkoff on Shutterstock)

Translating these CA2 findings from mice to people will require tools to see and measure these protective nets in living human brains. The research team notes that if perineuronal nets can be visualized with advanced brain imaging techniques, their degradation might serve as an early biomarker. Detecting CA2 net loss before social symptoms emerge could identify patients who might benefit from preventive treatment, assuming safe and effective drugs can be developed.

For decades, Alzheimer’s research has focused intensely on amyloid plaques and tau tangles, the two protein aggregates that define the disease at autopsy. Billions of dollars have funded efforts to clear these proteins from patient brains, with largely disappointing clinical results.

This study adds weight to an emerging perspective. Put another way, maybe we’ve been looking in slightly the wrong direction. Toxic protein accumulation clearly plays a role, but the destruction of extracellular matrix and protective structures like perineuronal nets may be equally important (or even primary) in causing specific symptoms.

The extracellular environment doesn’t just provide structural support for neurons. It regulates synaptic function, controls what molecules can reach neurons, maintains the proper ionic environment for electrical signaling, and modulates plasticity. When this environment deteriorates, neurons might remain alive but unable to function properly.

Previous studies have documented altered extracellular matrix and disrupted perineuronal nets in human Alzheimer’s brains, though most focused on the classic PNN-wrapped inhibitory neurons found throughout the brain rather than the unusual excitatory neuron nets in CA2. This oversight meant the connection to social memory went unmade.

The current findings reframe social recognition loss from a mysterious symptom to an explainable consequence of specific biological events: matrix metalloproteinases operating in overdrive, perineuronal nets disintegating, CA2 neurons losing their protection, and social memory circuits failing.

For families enduring the progression of Alzheimer’s in a loved one, this mechanistic understanding offers something beyond scientific satisfaction. It transforms “Mom doesn’t recognize me anymore” from an incomprehensible tragedy into a problem with identifiable causes and, potentially, solutions. The moment when recognition fades from a parent’s eyes remains devastating. But knowing why it happens in these mouse models, and seeing preliminary evidence that intervention might prevent it, provides a foundation for hope that future families might be spared this particular cruelty.


Paper Summary

Methodology

The researchers used 5XFAD mice, a well-established model of Alzheimer’s disease that harbors five mutations across two human genes (amyloid precursor protein and presenilin-1). They assessed social memory using a three-trial direct social interaction test where mice were introduced to novel mice and then re-introduced to familiar ones after intervals. Perineuronal nets were visualized using Wisteria floribunda agglutinin staining and confocal microscopy. The team employed genetic approaches (AAV-mediated Cre recombinase to delete aggrecan in the CA2 region of conditional knockout mice) and enzymatic methods (chondroitinase ABC injection) to selectively disrupt perineuronal nets. Bulk RNA sequencing of microdissected CA2 tissue revealed gene expression changes. Matrix metalloproteinase inhibitor GM6001 was administered intraperitoneally daily for one month starting at five months of age.

Results

At six months of age and beyond, 5XFAD mice showed profound disruption of CA2 perineuronal nets while other hippocampal regions showed only subtle changes. This net loss coincided precisely with impaired social recognition memory, though object recognition memory remained normal. Similar CA2 perineuronal net disruption appeared in J20 and 3XTg Alzheimer’s mouse models. Neuronal density in CA2 remained unchanged at ages when nets were disrupted and social memory impaired. Genetic deletion of aggrecan (a key perineuronal net component) specifically in CA2 of wild-type mice reproduced the social memory deficits. Enzymatic digestion of CA2 nets also impaired social memory, but nets regrew by 14 days post-injection and social memory returned. RNA sequencing revealed upregulation of multiple matrix metalloproteinases and related enzymes alongside relatively stable expression of net synthesis genes. Treatment with broad-spectrum matrix metalloproteinase inhibitor GM6001 preserved CA2 perineuronal nets and prevented social memory deficits in 5XFAD mice.

Limitations

The study used mouse models that may not fully recapitulate all aspects of human Alzheimer’s disease. Translating these CA2 findings from mice to people will require tools to see and measure these protective nets in living human brains. The genetic knockout approach removed aggrecan core protein as well as attached sugar chains, whereas the pathological condition in Alzheimer’s may primarily affect the sugar chains while leaving core proteins intact. The enzymatic disruption method (chondroitinase ABC) sometimes affected areas beyond CA2, including nearby cortical and hippocampal regions, though these areas have lower perineuronal net density and are not implicated in social memory. GM6001 is a broad-spectrum inhibitor affecting multiple matrix metalloproteinases, so the study could not determine which specific enzymes are most critical. The treatment duration was relatively short (one month), so longer-term efficacy and safety remain unknown.

Funding and Disclosures

This work was supported by National Institutes of Health grants R01AG065836, R01NS036692, and R01NS123069 awarded to Harald Sontheimer, as well as The Owens Family Foundation grant to Harald Sontheimer and Wagner Fellowship and Double Hoo Fellowship awarded to Lata Chaunsali. All authors declared no conflicts of interest.

Publication Details

Chaunsali L, Li J, Fleischel E, Prim CE, Kasprzak I, Jiang S, Hou S, Escalante M, Cope EC, Olsen ML, Tewari BP, Sontheimer H. “Degradation of perineuronal nets in hippocampal CA2 explains the loss of social cognition memory in Alzheimer’s disease,” was published October 22, 2025 in Alzheimer’s & Dementia. 2025;21:e70813. DOI: 10.1002/alz.70813

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Reply